Roffman Miller Associates’s uniQure QURE Stock Holding History

Roffman Miller Associates’s Portfolio QURE Stock Details QURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,650	Closed	-$30.4K	–	139
2023 Q2	$30.4K	Buy	+2,650	New	+$50.2K	﹤0.01%	90

Other funds holding QURE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

IBT

International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Roffman Miller Associates's QURE Position: Q3 2023 in Review

Roffman Miller Associates sold out of uniQure (QURE) in Q3 2023, closing a stake of 2,650 shares — an estimated $30.4K sold.

Roffman Miller Associates first reported a position in QURE in Q2 2023 and held it in 1 quarter. The position peaked at $30.4K in Q2 2023. 160 funds tracked by Wall St. Rank hold QURE as of Q3 2023.

Roffman Miller Associates reported no remaining uniQure position as of Q3 2023 after selling out during the quarter.
Roffman Miller Associates sold 2,650 uniQure shares in Q3 2023, an estimated $30.4K.
Roffman Miller Associates first reported a position in uniQure in Q2 2023 and held it in 1 quarter.
Roffman Miller Associates's uniQure position peaked at $30.4K in Q2 2023.
160 funds tracked by Wall St. Rank held uniQure as of Q3 2023.

Based on Roffman Miller Associates's 13F filing for Q3 2023, filed 9 Nov 2023.